Stockscreener 앱 받기
13.94
0.14%
-0.02
시장 영업 전:
13.94
전일 마감가:
$13.96
열려 있는:
$13.95
하루 거래량:
913.77K
Relative Volume:
0.31
시가총액:
$1.00B
수익:
-
순이익/손실:
$-192.96M
주가수익비율:
-4.2242
EPS:
-3.3
순현금흐름:
$-167.04M
1주 성능:
+0.22%
1개월 성능:
+0.94%
6개월 성능:
+428.03%
1년 성능:
+760.49%
1일 변동 폭
$13.94
$13.96
1주일 범위
$13.89
$13.97
52주 변동 폭
$0.783
$25.00
Ventyx Biosciences Inc Stock (VTYX) Company Profile
명칭
Ventyx Biosciences Inc
전화
(760) 407-6511
주소
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
Compare VTYX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VTYX
Ventyx Biosciences Inc
|
13.94 | 1.00B | 0 | -192.96M | -167.04M | -3.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.24 | 117.59B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
778.97 | 79.81B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
834.55 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.28 | 42.67B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
351.27 | 39.11B | 4.98B | 69.60M | 525.67M | 0.5198 |
Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-05 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-03-12 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2024-03-12 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-11-07 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-11-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-07 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2023-11-07 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-11-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-06-14 | 재개 | Credit Suisse | Outperform |
| 2023-03-21 | 개시 | Wells Fargo | Overweight |
| 2022-12-19 | 개시 | Goldman | Buy |
| 2022-11-17 | 개시 | Morgan Stanley | Overweight |
| 2022-09-07 | 개시 | Stifel | Buy |
| 2022-09-01 | 개시 | H.C. Wainwright | Buy |
| 2022-05-09 | 개시 | Credit Suisse | Outperform |
| 2022-03-31 | 개시 | Canaccord Genuity | Buy |
| 2022-02-01 | 개시 | Oppenheimer | Outperform |
| 2021-11-15 | 개시 | Jefferies | Buy |
| 2021-11-15 | 개시 | Piper Sandler | Overweight |
모두보기
Ventyx Biosciences Inc 주식(VTYX)의 최신 뉴스
Halper Sadeh LLC is Investigating Whether VAL, STKL, VTYX are Obtaining Fair Deals for their Shareholders - GlobeNewswire
Ventyx Biosciences Investor Alert: Kahn Swick & Foti, LLC Investi - The National Law Review
Panic Selling: Does Ventyx Biosciences Inc have a sustainable dividendForecast Cut & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Ventyx Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ventyx Biosciences, Inc.VTYX - Business Wire
Halper Sadeh LLC Encourages STEL, GORO, SKYT, VTYX Shareholders to Contact the Firm to Discuss Their Rights - InsideNoVa.com
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--SKYT, GORO, STEL, and VTYX - Benzinga
Does Ventyx Biosciences Inc offer margin of safetyWeekly Profit Report & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Lilly-Ventyx US premerger waiting period set to expire Feb. 23 - MLex
Ventyx Biosciences Sets March 3, 2026 Vote on Eli Lilly $14-Per-Share Cash Merger - TipRanks
Aug Movers: Is QMCO stock a hidden gemEarnings Performance Report & Stepwise Trade Signal Implementation - baoquankhu1.vn
Chipmakers Recap: Does Ventyx Biosciences Inc meet Warren Buffetts criteriaJuly 2025 Technicals & Growth Focused Entry Reports - baoquankhu1.vn
Short Interest in Ventyx Biosciences, Inc. (NASDAQ:VTYX) Drops By 37.7% - MarketBeat
Will Ventyx Biosciences Inc. benefit from rate cutsEarnings Beat & Daily Price Action Insights - mfd.ru
Halper Sadeh LLC Encourages NATH, VTYX, SKYT Shareholders to Contact the Firm to Discuss Their Rights - marketscreener.com
Assessing Ventyx Biosciences (VTYX) Valuation After Sharp Share Price Momentum And A High P/B Multiple - Yahoo Finance
Ventyx Biosciences (VTYX) Price Target Increased by 12.94% to 13.99 - MSN
Ventyx Biosciences Investor Alert: Kahn Swick & Foti, LLC Invest - GuruFocus
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger—VTYX, ALEX, RVYL, and FFWM - morningstar.com
Ventyx Biosciences approves cash bonus awards for executives ahead of planned merger - Investing.com Nigeria
Ventyx Biosciences approves cash bonus awards for executives ahead of planned merger By Investing.com - Investing.com South Africa
Ventyx Biosciences Sets Special Cash Bonuses Amid Lilly Merger - TipRanks
Institution Moves: Is Ventyx Biosciences Inc forming a double bottomQuarterly Portfolio Summary & Safe Entry Trade Reports - baoquankhu1.vn
Aug Update: Can Caledonia Mining Corporation Plc be the next market leaderMarket Rally & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Does Ventyx Biosciences Inc. meet Warren Buffett’s criteria2025 Trade Ideas & Expert Curated Trade Setups - baoquankhu1.vn
Halper Sadeh Investigates Ventyx and Sun Country Transactions - Intellectia AI
Market Fear: Will Ventyx Biosciences Inc stock hit new highs in YEAR2025 Support & Resistance & Reliable Intraday Trade Plans - baoquankhu1.vn
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nathan’s Famous, Inc. (Nasdaq – NATH), Lisata Therapeutics, Inc. (Nasdaq – LSTA), Sun Country Airlines Holdings, Inc. (NasdaqSNCY), Ventyx Biosciences, Inc. (Nasdaq - GlobeNewswire Inc.
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
Published on: 2026-01-21 17:52:30 - baoquankhu1.vn
Does Ventyx Biosciences Inc. stock reflect fundamentalsPortfolio Return Summary & Weekly Top Stock Performers List - bollywoodhelpline.com
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Short Interest Update - MarketBeat
Will Ventyx Biosciences Inc. stock split attract more investorsMarket Sentiment Summary & Entry Point Confirmation Alerts - bollywoodhelpline.com
Eli Lilly Acquires Ventyx Biosciences for $1.2 Billion, Strategizing Beyond Weight Management Drugs - Intellectia AI
Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026? - Finviz
Halper Sadeh Investigates ON24, Ventyx, and Sun Country for Potential Violations - Intellectia AI
Risk Off: Can RAPT Therapeutics Inc benefit from deglobalizationJuly 2025 Spike Watch & Stepwise Swing Trade Plans - baoquankhu1.vn
Analyst Calls: Will Ventyx Biosciences Inc stock hit new highs in YEARQuarterly Portfolio Summary & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Eli Lilly Acquires Ventyx Biosciences for $1.2 Billion, Expanding Drug Pipeline - Intellectia AI
Citizens Financial Group Inc. RI Takes Position in Ventyx Biosciences, Inc. $VTYX - MarketBeat
Eli Lilly’s $1.2 Billion Acquisition of Ventyx Biosciences: Bridging the Gap Between Weight Loss and Chronic Inflammation - FinancialContent
Aug Sectors: What are Ventyx Biosciences Incs earnings expectationsWall Street Watch & Free Long-Term Investment Growth Plans - baoquankhu1.vn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc.VTYX - yourwyominglink.com
Daily Breeze - FinancialContent
Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns - Finviz
Halper Sadeh LLC Encourages VTYX, SNCY, EKSO Shareholders to Contact the Firm to Discuss Their Rights - marketscreener.com
Halper Sadeh LLC Encourages VTYX, FONR, SNCY, FFIC Shareholders to Contact the Firm to Discuss Their Rights - marketscreener.com
Upcoming Events - FinancialContent
Ventyx Biosciences Inc (VTYX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Ventyx Biosciences Inc 주식 (VTYX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Mohan Raju | CEO AND PRESIDENT |
Dec 18 '25 |
Sale |
7.72 |
47,345 |
365,461 |
2,372,863 |
| Nuss John | CHIEF SCIENTIFIC OFFICER |
Dec 17 '25 |
Option Exercise |
0.00 |
34,930 |
0 |
502,156 |
| Nuss John | CHIEF SCIENTIFIC OFFICER |
Dec 18 '25 |
Sale |
7.72 |
12,675 |
97,840 |
489,481 |
2.09%
2.01%
자본화:
|
볼륨(24시간):